Results 121 to 130 of about 345,077 (288)

Hormone Replacement Therapy for Menopausal Symptoms and the Risk of Cardiometabolic Disease: Current Evidence and Future Directions

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong, Sarah Hillman, Sharon Dixon, Anupa Shah, Radha Venkatakrishnan, Jeremy W. Tomlinson   +5 more
wiley   +1 more source

Daily supplement of sesame oil prevents postmenopausal osteoporosis via maintaining serum estrogen and aromatase levels in rats

Scientific Reports
Estrogen deficiency is one of the main causes of postmenopausal osteoporosis in elderly women. Hormone replacement therapy has been employed to manage postmenopausal osteoporosis; however, it has raised concerns related to heart attacks and breast cancer.
Che-Chia Hsu, Po-Yen Ko, Ting-Hsien Kwan, Ming-Yie Liu, I.-Ming Jou, Chi-Wei Lin, Po-Ting Wu   +6 more
doaj   +1 more source

Osteoporosis self-assessment tool for Asians and calcaneal quantitative ultrasound for identifying primary osteoporosis in Taiwanese postmenopausal women

Frontiers in Endocrinology
ObjectivesThis study compares Osteoporosis Self-Assessment Tool for Asians (OSTA) and Calcaneal Quantitative Ultrasound (QUS) to detect primary osteoporosis among Taiwanese postmenopausal women and assess the consistency between both methods.Methods8,883
Dung-Huan Liu, Dung-Huan Liu, Dung-Huan Liu, Chih-Sheng Lin, Chih-Sheng Lin, Chih-Sheng Lin, Pei-Ching Wu, Pei-Ching Wu, Pei-Ching Wu   +8 more
doaj   +1 more source

Biochemical bone biomarkers in plasma cell dyscrasias

British Journal of Haematology, EarlyView.
Visual abstract depicting that bone turnover markers reflect dynamic alterations in bone remodelling across the spectrum of plasma cell dyscrasias but remain limited by assay variability, biological confounding and incomplete integration with imaging and risk stratification.
Guido Nador, Rohit Vijjhalwar, Muhammad Kassim Javaid, Claire M. Edwards, Karthik Ramasamy   +4 more
wiley   +1 more source

Evaluation of Serum Osteocalcin and Osteopontin Levels as Bone Biochemical Markers in Postmenopausal Women.

مجله كليه طب الكندي, 2013
Background: Studies discussing the correlation between biochemical markers of bone turnover and the diagnosis of osteoporosis in postmenopausal Iraqi women are rare.
Kisma M Turki, Mohammed H Al-Osami, Nawar S Mohammed   +2 more
doaj  

Deciphering epigenetic regulation in postmenopausal osteoporosis: Current and future perspectives

View
Postmenopausal osteoporosis is the most prevalent form of osteoporosis, affecting approximately 33% of postmenopausal women globally and representing a major cause of age‐related disability and mortality.
Xiumei Tang, Meiru Chen, Guixuan Xu, Yuan Li, Sen Guo, Yufeng Huang, Zhaoliang Hou, Xiaoling Hou, Zhijian Wei, Wenzhao Wang, Bing Ning   +10 more
doaj   +1 more source

Parathyroid carcinoma as an overlooked etiology of osteoporosis in postmenopausal women: a case report

Frontiers in Endocrinology
Parathyroid carcinoma (PC), an extremely rare endocrine malignancy, disrupts calciumphosphorus homeostasis and lead to musculoskeletal system disorders including osteoporosis, bone pain and pathological fractures.
Jing Su, Shiqiong Lei, Meiyuan Jin, Hongzhi Hu, Wenshan He   +4 more
doaj   +1 more source

Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis.

International Journal of Surgery, 2019
OBJECTIVE This meta-analysis aims to compare the efficacy of teriparatide and bisphosphonates for reducing vertebral fracture risk and bone mineral density (BMD) in lumbar spine and femoral neck in postmenopausal women with osteoporosis.
Fei Yuan, Wen-Ke Peng, Caihong Yang, Jinping Zheng   +3 more
semanticscholar   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Weight-adjusted waist index as a new predictor of osteoporosis in postmenopausal patients with T2DM

Scientific Reports
This study aimed to investigate the predictive value of the weight-adjusted waist index (WWI) for osteoporosis in postmenopausal patients with type 2 diabetes mellitus (T2DM).
Guohui Du, Linna Zeng, Jingyuan Lan, Junru Liu, Xing Wang, Lina Sun, Dongmei Fan, Ning Wang, Lanyu Lu, Bowei Liu, Fuzai Yin   +10 more
doaj   +1 more source